Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biochemical processes in schizophrenia: an update

M B Bowers

    Schizophrenia Bulletin
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    This review examines biochemical processes in schizophrenia, integrating neurobiology with clinical factors. It updates research on dopamine, monoamine oxidase, and other biological markers influencing psychosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clozapine in the treatment of aggression in an adolescent with autistic disorder.

    The Journal of clinical psychiatry·2001
    Same author

    Antidepressant-associated mania and psychosis resulting in psychiatric admissions.

    The Journal of clinical psychiatry·2001
    Same author

    Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle.

    Journal of cell science·2001
    Same author

    Lamotrigine as prophylaxis against steroid-induced mania.

    The Journal of clinical psychiatry·1999
    Same author

    Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

    Psychopharmacology·1999
    Same author

    Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.

    Journal of clinical psychopharmacology·1999
    Same journal

    The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

    Schizophrenia bulletin·2026
    Same journal

    Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse.

    Schizophrenia bulletin·2026
    Same journal

    Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

    Schizophrenia bulletin·2026
    Same journal

    Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    The Key to Clozapine Mystery May Lie in its Shape.

    Schizophrenia bulletin·2026
    See all related articles

    Area of Science:

    • Neurobiology
    • Psychiatry
    • Biochemistry

    Background:

    • Schizophrenia research increasingly integrates neurobiological findings with clinical observations.
    • Understanding biochemical processes is crucial for advancing schizophrenia nosology.

    Purpose of the Study:

    • To review current knowledge on biochemical processes in schizophrenia.
    • To highlight the integration of neurobiology and clinical factors in understanding the disorder.

    Main Methods:

    • Literature review of neurobiological and clinical research in schizophrenia.
    • Synthesis of information on key biochemical hypotheses and factors.

    Main Results:

    • Updated perspectives on the dopamine hypothesis and monoamine oxidase research.

    Related Experiment Videos

  • Review of post-mortem studies, endorphins, and endogenous hallucinogens.
  • Inclusion of immunological, viral factors, and serum creatine phosphokinase in biochemical analyses.

    • Conclusions:

    • Neurobiological insights are increasingly informing the clinical understanding of schizophrenia.
    • A comprehensive biochemical perspective is essential for schizophrenia research and treatment.